Tags biotech investment Merck Drops $9.2 Billion to Snag Experimental Flu Drug — A Bold Bet Amid Keytruda Patent Cliff businessx November 15, 2025 Merck Makes Massive $9.2 Billion Move to Strengthen Flu Pipeline Merck has just made headlines with a blockbuster acquisition: the
